Prevalence and Clinical Implication of Double Mutations in Hypertrophic Cardiomyopathy

Double mutations in patients with hypertrophic cardiomyopathy are much less common than previously estimated. With the exception of double radical MYBPC3 mutations, there is little data to guide clinical decision making in cases with double mutations.